NR4A1 and breast cancer: Further investigations are needed to explore subtypes of breast cancer, genetic background of hormone-related breast cancer, and the association between BRCA mutations and the incidence of hormone receptor-positive breast cancer.<h4>Registration number</h4>PROSPERO(CRD42021281336).